Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$40.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.37M
Operating Margin
0.00%
TTM Avg
-109.31%
3Y Avg
-251.39%
5Y Avg
-169.83%
Market Cap
$41.92M
Operating Margin
-5.63%
TTM Avg
-15.71%
3Y Avg
-54.38%
5Y Avg
-79.38%
Market Cap
$38.78M
Operating Margin
-380.85%
TTM Avg
-275.43%
3Y Avg
-246.44%
5Y Avg
-2168.10%
Market Cap
$42.32M
Operating Margin
-90.49%
TTM Avg
-103.23%
3Y Avg
-126.36%
5Y Avg
-149.14%
Market Cap
$42.81M
Operating Margin
-466.16%
TTM Avg
-484.55%
3Y Avg
-719.99%
5Y Avg
-1266.78%
Market Cap
$38.47M
Operating Margin
1.17%
TTM Avg
-3.67%
3Y Avg
-2.94%
5Y Avg
-1.63%
Market Cap
$43.14M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
Market Cap
$38.00M
Operating Margin
7.92%
TTM Avg
3.07%
3Y Avg
-12.13%
5Y Avg
-21.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.69M | 0.00% | 0.00% | N/A | N/A |
| Veru Inc. (VERU)vs › | $40.37M | 0.00% | -109.31% | -251.39% | -169.83% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -5.63% | -15.71% | -54.38% | -79.38% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $38.78M | -380.85% | -275.43% | -246.44% | -2168.10% |
| CVRx, Inc. (CVRX)vs › | $42.32M | -90.49% | -103.23% | -126.36% | -149.14% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.81M | -466.16% | -484.55% | -719.99% | -1266.78% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | 1.17% | -3.67% | -2.94% | -1.63% |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | -1.45% | 4.45% | -26.46% | -35.98% |
| Nephros, Inc. (NEPH)vs › | $38.00M | 7.92% | 3.07% | -12.13% | -21.71% |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
